SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer.
J Clin Oncol
; 33(14): 1601-8, 2015 May 10.
Article
in En
| MEDLINE
| ID: mdl-25847934
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Biomarkers, Tumor
/
Receptor, IGF Type 1
/
Prostate-Specific Antigen
/
Antineoplastic Agents, Hormonal
/
Androgen Antagonists
/
Antibodies, Monoclonal
/
Neoplastic Cells, Circulating
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Oncol
Year:
2015
Document type:
Article
Country of publication:
United States